Early Data With Olaratumab in Soft Tissue Sarcoma
3 Visualizzazioni
• 07/18/23
0
0
Incorporare
administrator
Iscritti
The panelists, Brian Van Tine, MD, PhD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD; discuss phase I/II data with olaratumab and its mechanism of action.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti